Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses

Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses

US Patent 6734013 · Granted May 11, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for targeting activin signaling to treat cancer2025
Methods of treating or preventing cancer with an agent that depletes tregs and a2025
Biodegradable biomimetic particles2024
Immunoswitch nanoparticles for reprogrammed T cell responses2024
Nanoscale artificial antigen presenting cells2024
Combination of immunotherapy with local chemotherapy for the treatment of malign2023
Treating or preventing adverse liver conditions2023
Checkpoint blockade and microsatellite instability2023
Bacterial biofilms and cancer2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023